Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.5%

1 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 1

3(42.9%)

Phase 3

3(42.9%)

Phase 2

1(14.3%)

7Total

Phase 1(3)

Phase 3(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT00832039Phase 3Completed

Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis

Role: collaborator

NCT01601938Phase 2Withdrawn

Selenium Replacement and Serum Selenium Level in Severe Sepsis and Septic Shock Patients

Role: collaborator

NCT01355107Completed

Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease

Role: collaborator

NCT00260767Phase 1Unknown

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

Role: lead

NCT00214747Phase 1Unknown

An Imaging Trial of the Distribution of Topical Gel Formulations in the Human Vagina

Role: lead

NCT00214812Phase 1Unknown

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

Role: lead

NCT00130078Phase 3Unknown

Trial of SAVVY Vaginal Gel and HIV in Nigeria

Role: lead

NCT00129532Phase 3Unknown

Trial of SAVVY and HIV in Ghana

Role: lead

All 8 trials loaded